Cart
sales@molnova.com
Levofloxacin N-oxide
CAS No. 117678-38-3
Levofloxacin N-oxide( —— )
Catalog No. M28153 CAS No. 117678-38-3
Levofloxacin N-oxide is an impurity isolated from levofloxacin.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 87 | In Stock |
|
| 2MG | 37 | In Stock |
|
| 5MG | 65 | In Stock |
|
| 10MG | 102 | In Stock |
|
| 25MG | 169 | In Stock |
|
| 50MG | 231 | In Stock |
|
| 100MG | 323 | In Stock |
|
| 200MG | 454 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLevofloxacin N-oxide
-
NoteResearch use only, not for human use.
-
Brief DescriptionLevofloxacin N-oxide is an impurity isolated from levofloxacin.
-
DescriptionLevofloxacin N-oxide is an impurity isolated from levofloxacin.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor5-HT4
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number117678-38-3
-
Formula Weight377.4
-
Molecular FormulaC18H20FN3O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESFC1=C(N2CCN(CC2)(C)=O)C(OC[C@H](C)N3C=C(C(O)=O)C4=O)=C3C4=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tadayoshi Mikami, et al. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs. J Pharmacol Exp Ther. 2008 Apr;325(1):190-9.
molnova catalog
related products
-
PAR-4 Agonist Peptid...
PAR-4 Agonist Peptide, amide(2TFA) is an agonist of proteinase-activated receptor-4 (PAR-4).
-
(D-Phe5,Cys6·11,N-Me...
(D-Phe5,Cys6,11,N-Me-D-Trp8)-Somatostatin-14 (5-12) amide (Compound 4) is a somatostatin analog with Kds of 0.61, 11.05, 23.5, 1200 and >1000 nM for SSTR5, SSTR3, SSTR2, SSTR1 and SSTR4, respectively.
-
LC-MB12
LC-MB12 is an orally active, selective and potent PROTAC FGFR2 complex that degrades FGFR2.LC-MB12 has antiproliferative and antitumor activity.
